v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:                
Net loss $ (1,556) $ (10,780) $ (9,401) $ (12,689) $ (15,800) $ (31,929)    
Adjustments to reconcile net loss to net cash used in operating activities:                
Depreciation and amortization         2,216 2,698    
Allowance for credit losses         (138) 382    
Inventory impairment         7 267    
Share-based compensation         2,543 4,667    
Non-cash interest expense         711 600    
Loss on extinguishment of debt         539      
Loss on disposal of property and equipment         375 45    
Changes in certain assets and liabilities:                
Accounts receivable, net         2,465 1,384    
Inventory         (772) (240)    
Net investments in sales-type leases         (15) 22    
Prepaid commission expense         1,995 840    
Prepaid expenses and other assets         (339) 3,813    
Accounts payable         (823) (77)    
Accrued expenses         (2,001) (3,302)    
Other liabilities         (398) (223)    
Deferred revenue         244 (229)    
Net cash used in operating activities         (9,191) (21,282) $ (20,400)  
Cash flows from investing activities:                
Purchases of property and equipment and capitalized software         (1,084) (585)    
Proceeds from the sale of property and equipment         25      
Net cash used in investing activities         (1,059) (585)    
Cash flows from financing activities:                
Payments of debt issuance costs         (55) (80)    
Proceeds from issuance of long-term debt           10,000    
Repayment of deferred and contingent consideration         (250)      
Repayment of long-term debt         (5,000)      
Payment for debt extinguishment costs         (250)      
Distribution to non-controlling interest         (423)      
Proceeds from exercises of stock options         2,202 13    
Payments to tax authorities for employee share withholding         (420)      
Net cash provided by financing activities         3,972 36,879    
Net increase (decrease) in Cash, Cash equivalents and Restricted cash         (6,278)     $ 15,012
Cash and cash equivalents and restricted cash and cash equivalents, beginning of period   $ 34,134   $ 19,459 34,134 19,459 19,459  
Cash and cash equivalents and restricted cash and cash equivalents, end of period 27,856   34,471   27,856 34,471 34,134 19,459
Reconciliation of cash and cash equivalents and restricted cash and cash equivalents to the consolidated balance sheet:                
Cash and cash equivalents 22,106   27,971   22,106 27,971 28,134  
Restricted cash and cash equivalents 5,750   6,500   5,750 6,500 6,000  
Total cash and cash equivalents and restricted cash and cash equivalents $ 27,856   $ 34,471   27,856 34,471 $ 34,134 $ 19,459
Supplemental disclosure of cash flow information:                
Cash paid for interest         5,847 5,474    
Transfer of inventory to property and equipment         155 75    
Supplemental disclosure of non-cash investing and financing activities:                
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses         48 30    
Secondary public offering                
Cash flows from financing activities:                
Proceeds from the issuance of common stock           20,700    
Payments of common stock offering issuance costs           (1,731)    
ATM Program                
Cash flows from financing activities:                
Proceeds from the issuance of common stock         8,577 8,313    
Payments of common stock offering issuance costs         $ (409) $ (336)